Michaela Schwarz Selected Research

Tyrosine Kinase Inhibitors

6/2012	Clinical cardiac safety profile of nilotinib.
11/2010	Thyroid dysfunction caused by second-generation tyrosine kinase inhibitors in Philadelphia chromosome-positive chronic myeloid leukemia.
4/2010	Impact of additional chromosomal aberrations and BCR-ABL kinase domain mutations on the response to nilotinib in Philadelphia chromosome-positive chronic myeloid leukemia.
3/2010	New developments in tyrosine kinase inhibitor therapy for newly diagnosed chronic myeloid leukemia.
8/2003	Imatinib in Philadelphia chromosome-positive chronic phase CML patients: molecular and cytogenetic response rates and prediction of clinical outcome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Michaela Schwarz Research Topics

Disease

14	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2014 - 01/2002
7	Philadelphia Chromosome 01/2015 - 10/2002
3	Leukemia 01/2022 - 10/2002
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022 - 01/2015
2	Neoplasms (Cancer) 01/2014 - 01/2013
2	Blast Crisis (Blast Phase) 10/2010 - 04/2010
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	Myocardial Infarction 01/2021
1	Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita) 01/2021
1	Primary Myelofibrosis (Myelosclerosis) 01/2020
1	Body Weight (Weight, Body) 11/2019
1	Sudden Infant Death (SID) 10/2017
1	Postoperative Nausea and Vomiting (PONV) 10/2017
1	Chronic Kidney Failure (Chronic Renal Failure) 08/2015
1	Critical Illness (Critically Ill) 08/2015
1	Renal Insufficiency (Renal Failure) 08/2015
1	Acute Kidney Injury (Acute Renal Failure) 08/2015
1	Neurodegenerative Diseases (Neurodegenerative Disease) 09/2014
1	Disease Progression 04/2014
1	Coronary Artery Disease (Coronary Atherosclerosis) 06/2012
1	Hyperthyroidism 11/2010
1	Hypothyroidism 11/2010
1	Autoimmune Thyroiditis (Lymphomatous Thyroiditis) 11/2010
1	Chromosome Aberrations (Chromosome Abnormalities) 04/2010
1	Parkinson Disease (Parkinson's Disease) 12/2008
1	Papillomavirus Infections 04/2003
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 04/2003
1	Carcinoma (Carcinomatosis) 04/2003
1	Acute Generalized Exanthematous Pustulosis 10/2002
1	Exanthema (Rash) 10/2002
1	Muscle Cramp (Cramp) 10/2002
1	Edema (Dropsy) 10/2002

Drug/Important Bio-Agent (IBA)

10	Imatinib Mesylate (Gleevec)FDA Link 04/2014 - 01/2002
5	nilotinib FDA Link 01/2015 - 04/2010
5	Tyrosine Kinase InhibitorsIBA 06/2012 - 08/2003
3	AcidsIBA 10/2017 - 01/2002
3	Phosphotransferases (Kinase)IBA 01/2014 - 10/2002
2	Glycoproteins (Glycoprotein)IBA 08/2003 - 01/2002
2	Pharmaceutical PreparationsIBA 04/2003 - 10/2002
1	AndrogensIBA 01/2021
1	Janus Kinase InhibitorsIBA 01/2020
1	Triglycerides (Triacylglycerol)IBA 11/2019
1	Glucose (Dextrose)FDA LinkGeneric 11/2019
1	CholesterolIBA 11/2019
1	Phosphates (Orthophosphate)IBA 10/2017
1	CatecholaminesIBA 10/2017
1	ElectrolytesIBA 10/2017
1	Starch (Cornstarch)IBA 08/2015
1	Human Serum Albumin FDA LinkGeneric 08/2015
1	KynurenineIBA 09/2014
1	Quinolinic AcidIBA 09/2014
1	Biological ProductsIBA 09/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2014
1	Ketoglutaric Acids (Ketoglutaric Acid)IBA 01/2013
1	5-hydroxymethylfurfural (hydroxymethylfurfural)IBA 01/2013
1	Dasatinib (BMS 354825)FDA Link 11/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 10/2003
1	Messenger RNA (mRNA)IBA 08/2003
1	Interferon-alpha (Interferon Alfa)IBA 08/2003
1	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2002
1	bcr-abl Fusion ProteinsIBA 01/2002

Therapy/Procedure

9	Therapeutics 01/2022 - 01/2002
2	Drug Therapy (Chemotherapy) 01/2022 - 04/2003
2	Hematopoietic Stem Cell Mobilization 03/2011 - 10/2003
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Consolidation Chemotherapy 01/2022
1	Length of Stay 08/2015
1	Transplantation 08/2011
1	Deep Brain Stimulation 12/2008